Trial: Pre-Exposure Prophylaxis to prevent HIV-1 acquisition within HIV-1 discordant couples [PartnersPrEP]
Phase: III
Product Being Tested: Daily oral TDF & daily oral TDF/FTC
Sponsor, funder, developer, collaborator: Bill and Melinda Gates Foundation; Moi University - Indiana University; Kenyatta National Hospital/University of Nairobi; CMR, Kemri-UCSF; Partners in Prevention - Thika
Total participants: 4,700
Countries: Kenya, Uganda
Trial sites in Kenya: Eldoret, Nairobi, Kisumu, Thika
Results expected: 2012
For more information: http://clinicaltrials.gov/ct2/show/NCT00557245
Back to Top ↑